We are live on ! Find out more
GLSI icon

Greenwich LifeSciences

51 hedge funds and large institutions have $11.2M invested in Greenwich LifeSciences in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

11% more funds holding

Funds holding: 4651 (+5)

1% more capital invested

Capital invested by funds: $11.1M → $11.2M (+$87K)

0.38% more ownership

Funds ownership: 8.84%9.21% (+0.38%)

Holders
51
Holders Change
+5
Holders Change %
+10.87%
% of All Funds
0.67%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
20
Reduced
11
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Osaic Holdings
51
Osaic Holdings
Arizona
$45 +$48 +5 New
CF
52
Corebridge Financial
Texas
-$28.5K -2,985 Closed
GI
53
GAMMA Investing
California
-$1.2K -126 Closed
TWD
54
True Wealth Design
Ohio
-$20 -2 Closed

GLSI Hedge Fund Activity: Q2 2025 in Review

51 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q2 2025, worth a combined $11.2M — up 0.78% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new GLSI positions and 3 closed out — a net gain of 6 holders — while 20 added to existing stakes and 11 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $534K. The largest seller was Corebridge Financial, exiting entirely with an estimated $28.5K sold.

  • 51 institutional investors held Greenwich LifeSciences (GLSI) as of Q2 2025, up from 46 in Q1 2025.
  • Funds reported $11.2M of Greenwich LifeSciences stock for Q2 2025, up 0.78% quarter-over-quarter.
  • 9 funds opened new Greenwich LifeSciences positions in Q2 2025 and 3 closed out, a net change of +6 holders.
  • The largest Greenwich LifeSciences buyer in Q2 2025 was Marshall Wace, an estimated $534K added.
  • The largest Greenwich LifeSciences seller in Q2 2025 was Corebridge Financial, an estimated $28.5K sold.

Based on aggregated 13F filings for Q2 2025.